Work

ARRY-520 Shows Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Dose-Escalation Study

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.1860.1860

Authors: Jatin J Shah, Jeffrey Zonder, Adam Cohen, Robert Z. Orlowski, Raymond Alexanian, Sheeba K Thomas, Donna Weber, Jonathan L. Kaufman, R. Donald Harvey, Duncan Walker, Kevin Litwiler, Sharon Karan, Brandi Hilder, Ann Marie Ptaszynski, Sagar Lonial

Institutions: The University of Texas MD Anderson Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Fox Chase Cancer Center, Winship Cancer Institute, Array BioPharma (United States), Emory University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587993401

FWCI: 1.514

Cites:

Cited by: 14

Related to: 10